SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001178913-10-002186
Filing Date
2010-08-20
Accepted
2010-08-20 15:01:55
Documents
5
Period of Report
2010-06-30
Filing Date Changed
2010-08-20

Document Format Files

Seq Description Document Type Size
1 10-Q zk1008696.htm 10-Q 356657
2 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 13019
3 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 13234
4 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 6505
5 EXHIBIT 32.2 exhibit_32-2.htm EX-32.2 6285
  Complete submission text file 0001178913-10-002186.txt   397415
Mailing Address 8905 REGENTS PARK DR, SUITE 210 TAMPA FL 33647
Business Address 8905 REGENTS PARK DR, SUITE 210 TAMPA FL 33647 813-428-3500
Laxai Pharma Ltd (Filer) CIK: 0000835688 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-17788 | Film No.: 101030057
SIC: 2860 Industrial Organic Chemicals
Assistant Director 6